- Home
- CENN vs DYAI Comparison
CENN vs DYAI Comparison
Compare CENN & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENN
- DYAI
- Stock Information
- Founded
- CENN 2013
- DYAI 1979
- Country
- CENN United States
- DYAI United States
- Employees
- CENN N/A
- DYAI N/A
- Industry
- CENN Auto Manufacturing
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CENN Consumer Discretionary
- DYAI Health Care
- Exchange
- CENN Nasdaq
- DYAI Nasdaq
- Market Cap
- CENN 35.8M
- DYAI 31.5M
- IPO Year
- CENN N/A
- DYAI 2004
- Fundamental
- Price
- CENN $1.36
- DYAI $1.14
- Analyst Decision
- CENN
- DYAI Strong Buy
- Analyst Count
- CENN 0
- DYAI 1
- Target Price
- CENN N/A
- DYAI $6.00
- AVG Volume (30 Days)
- CENN 102.0K
- DYAI 17.1K
- Earning Date
- CENN 11-12-2024
- DYAI 11-12-2024
- Dividend Yield
- CENN N/A
- DYAI N/A
- EPS Growth
- CENN N/A
- DYAI N/A
- EPS
- CENN N/A
- DYAI N/A
- Revenue
- CENN $37,052,841.00
- DYAI $3,364,548.00
- Revenue This Year
- CENN N/A
- DYAI $2.04
- Revenue Next Year
- CENN N/A
- DYAI $110.34
- P/E Ratio
- CENN N/A
- DYAI N/A
- Revenue Growth
- CENN 142.48
- DYAI 13.82
- 52 Week Low
- CENN $1.00
- DYAI $0.93
- 52 Week High
- CENN $25.00
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- CENN 58.62
- DYAI 53.97
- Support Level
- CENN $1.30
- DYAI $1.02
- Resistance Level
- CENN $1.30
- DYAI $1.15
- Average True Range (ATR)
- CENN 0.07
- DYAI 0.08
- MACD
- CENN 0.01
- DYAI 0.01
- Stochastic Oscillator
- CENN 50.00
- DYAI 93.38
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles. Its vehicles include Metro, Logistar 400, Logistar 200, Neibor 200, and ORV. The company's geographical segments include Europe, America, and Asia.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.